The dynamics of the minimal residual disease market are anticipated to change as the future of guided therapies, improvements in the next-generation sequencing detection methods, and the increased
The prevalence of amyotrophic lateral sclerosis has been rising over the past few years, which prompts the growing demand for treatment options. The increasing prevalence of amyotrophic lateral
Prostate cancer is the most common cancer in men and accounts for the second most cancer deaths among men globally. The rise in the number of cases of prostate cancer has led to growing government
The growth of the Huntington's disease market is expected to be mainly driven by less competitive scenarios, entry of innovative emerging therapies, rising prevalence, and geriatric population
The dynamics of the dermatomyositis market are anticipated to change in the coming years owing to the improvement in the rise in a number of healthcare spending across the world and rising cases